December 2019

In this interesting article entitled “A Faster, More Cost-Effective Alternative to Generic Bioequivalence”, Dr. Jag Shur, CEO of Nanopharm, an Aptar Pharma company, explores the challenges companies face in bringing generic respiratory and nasal therapies to market amidst a changing regulatory landscape.  He explains the Aptar Pharma Services range for accelerating and derisking OINDP development, and introduces the CPhI 2019 Award winning SmartTrack™ as an alternative to bioequivalence studies.

“Many retail brands are offering premium quality private label products that need to stand apart,” says Nathan Klettlinger, the market manager of food for Cincinnati-based ProAmpac. “Whether it be shape, size, color, texture material or finish — flexible packaging offers a multitude of options for standout packaging.”

Board Chairman, King Harris, stated, “We are delighted that Stephan will join and lead our strong management team. He has had an impressive career at Royal DSM NV and has played a key role in expanding its nutrition cluster.”

Aptar’s Executive Vice President and Chief Financial Officer, Bob Kuhn, will present at the Bank of America Merrill Lynch 2016 Paper, Packaging and Builders Conference in Boston, Mass., on December 14.

Other Aptar executives in attendance include Salim Haffar, President of Aptar Pharma, and Matt DellaMaria, Vice President of Investor Relations.

Third Quarter 2017 Summary

Led by Stephan Tanda, President and CEO; other presenters included Bob Kuhn, Executive Vice President and CFO; Shiela Vinczeller, CHRO; Eldon Schaffer; President of Aptar Beauty + Home; Gael Touya, President of Aptar Pharma; Marc Prieur, President of Aptar Food + Beverage; and Xiangwei Gong, President of Aptar Asia.

This strategic investment brings complementary and distinctive capabilities to Aptar including high speed stamping and anodization, metal and plastic decoration and differentiated lipstick masstige mechanism design and manufacturing. This investment positions Aptar well to capitalize on growth potential in the Asian color cosmetics market, while further strengthening Aptar’s ability to serve customers focused on the color cosmetics markets.

As previously announced, Aptar will hold a conference call on Friday, November 1, 2019 at 8:00 a.m. Central Time to discuss the Company’s third quarter results for 2019. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investor Relations page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investor Relations page of the website.

Crystal Lake, Illinois, October 31, 2019 — AptarGroup, Inc. (NYSE:ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions, today reported its third quarter 2019 financial results. In addition, Aptar has acquired Noble International (Noble), a leader in drug delivery training devices and patient onboarding and announced certain segment leadership appointments.

Third Quarter 2019 Summary

(SIEgER is a German play on words: “SIE” stands for SHE, “ER” stands for HE, while the term itself means “WINNER”.)

Seven regional juries, comprised of representatives from the Bavarian economy, trade unions and the governments’ economic departments, had previously received a personal impression of each competitor’s family-friendliness by means of an on-site visit and then selected the 41 “best practice” companies in the region from 111 entrants.